INR Test Meter Market Snapshot (2023 to 2033)

The anticipated size of the INR test meter market in 2022 was US$ 1,268.3 million and is estimated to be US$ 1,336.1 million in 2023. The rise in the prevalence of cardiovascular diseases and blood disorders across the globe is considered one of the primary drivers that will raise the growth of the INR test meter market. Future Market Insights has mentioned in its reports that the INR test meter market will expand at a CAGR of 6.3% between 2023 and 2033, totaling around US$ 2,453.3 million by 2033.

INR test meter is a battery-operated, portable device that is used to track a patient's response to warfarin. Meter contains a display screen that shows the results as well as a slot for meter-specific test strips. Test strip is introduced into the meter, and blood is drawn with a lancet (a medical pricking needle) and applied to the test strip.

Meter reads the test strip, counts the number of seconds it takes for the blood to clot, and calculates the result using a standardized formula called the International Normalized Ratio (INR). Providers and patients use the INR to evaluate if the warfarin dose is proper. The USA Food and Drug Administration regulates INR test meters and test strips as medical devices.

Attributes Details
Projected Forecast Value (2022) US$ 1,268.3 million
Projected Forecast Value (2023) US$ 1,336.1 million
Projected Forecast Value (2033) US$ 2,453.3 million
Growth rate 6.3% CAGR
Forecast period 2023 to 2033

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

INR Test Meter Market Historical Analysis (2017 to 2022) Vs. Forecast Outlook (2023 to 2033)

The global INR test meter market grew at a CAGR of 4.5% between 2017 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 6.3% between 2023 and 2033. Future Market Insights (FMI) projects that the INR test meter market contributed approximately 72.8% of the overall US$ 1.66 billion of the global point-of-care coagulation testing devices market in 2021.

Standard test for patients on vitamin K antagonists (VKA), is the international normalized ratio (INR). It is also helpful in the evaluation of a patient's risk of bleeding or coagulation status. As INR varies between patients, patients taking oral anticoagulants monitor their INR to adjust their VKA doses. Blood thinner warfarin is used to prevent and treat blood clots. Patient's warfarin dose is decided by their age, overall health, and genetic factors. Patient care includes regular INR monitoring and patient-centered INR education.

INR is derived from prothrombin time (PT). PT and INR are important parameters to keep track of a patient's coagulation status, particularly if they're using VKAs. Although the PT/INR is beneficial for monitoring the coagulation state. Activated partial thromboplastin time (aPTT), which assesses the intrinsic and common coagulation pathways, is frequently used in conjunction with PT/INR. Combination of PT/INR and aPTT values can confirm the diagnosis of a range of hematologic diseases.

Patients who benefit from PT tests are those who have thromboembolic complications requiring oral anticoagulation therapy (OAT), critical coagulopathy (such as SIC), haemorrhagic conditions, etc., triggered by hepatic or renal disorders, or diseased states such as dengue haemorrhagic fever, and others. Patients with cardiovascular disorders (CVD), such as stroke, atrial fibrillation, transient ischemic attacks, myocardial infarction, valve prosthesis, pulmonary embolism, venous thrombosis, and others, are among the most common candidates for life-long oral therapy to prevent intravascular clot formation.

What are the Key Opportunities for the INR Test Meter Market Manufacturers?

Application of PT/INR Testing in Smartphone Sensors

The application of PT/INR testing in smartphone sensors is expected to result in a cost-effective blood clot detection device. Custom electronics and hardware are not necessary for using smartphone hardware for medical purposes.

The use of such hardware reduces the development costs generally associated with obtaining regulatory approvals. The United States of America’s Food and Drug Administration (FDA) does not control smartphone hardware and only governs unique software features under its Mobile Medical Applications (MMA) and Software as a Medical Device (SaMD) regulations.

The FDA has approved or authorized commercially available MMAs that perform medical diagnostics using sensors such as microphones and cameras. INR testing on whole blood samples using a point-of-care testing (POCT) device at a thrombosis clinic is adequate and beneficial. Due to the ease, shortened waiting time, and painless finger stick technique, it significantly improves the patient experience.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining Demand for INR Test Meter?

Availability of Various Home PT/INR Testing Modules

Despite the availability of various home PT/INR testing modules, finding a cost-effective and accurate PT/INR test remains a challenge. In the United States of America, patients are only in the therapeutic range roughly 64% of the time. Patients in developing nations such as Botswana, Uganda, and India fall into this category just 40% of the time due to less testing. Despite the potential benefits of home PT/INR testing, these devices are expensive, limiting their applicability in resource-constrained settings.

Especially in senior patients with various comorbidities, excessive waiting times can lead to greater patient dissatisfaction. After a thorough cost-benefit analysis, robust technology could be explored in order to deliver quick results while also ensuring patient convenience and satisfaction. Such factors cumulatively hamper the market growth for INR test meters, and call for solutions to meet the requirements which hinder the overall sales and adoption of INR test meters across the globe.

Country-wise Insights

What Makes North America a Lucrative Market for INR Test Meters?

Introduction of Coagulation Testing in the United States to Improve INR Test Meter Demand

The United States is expected to hold a market share of 32.1% and considerably dominates North America’s INR test meter market with a total share of about 35.6% in 2022 and is expected to continue to experience the same growth throughout the forecast period.

With the introduction of anticoagulants, the rising prevalence of blood clotting diseases, and the growing need for coagulation testing devices, North America is expected to be a prominent market for INT test meters. In North America, the United States is expected to be the largest market for coagulation testing, followed by Canada. This is anticipated to drive the demand for the INR test meter market in the United States, facilitating growth in North America through 2032.

What is the Demand Outlook for the Europe’s INR Test Meter Market?

Germany INR Test Meter Market to Benefit from Strong Presence of Key Manufacturers

Germany held a market share of nearly 3.6% in the Europe INR test meter market with a market share of 32.0%. Growth in the Germany INR test meter market is expected to witness strong growth with the presence of large medical device players, such as Merck KGaA, and SIEMENS Healthcare Diagnostics Products GmbH.

Key players in the market are focusing on new product launches and prototype products which have demonstrated the functioning of novel coagulation testing platforms and their functions. This is expected to push the demand for INR test meters in Germany.

Will Asia Pacific Emerge as a Highly Lucrative Market for INR Test Meter?

Inflammation and Hysterical Viral Replication Promotes Hypercoagulability and Vascular Damage

The INR test meter market in China expanded at a CAGR of 10.1% share in the East Asia market, surpassing US$ 67.1 million in 2021. Inflammation and hysterical viral replication promote hypercoagulability and vascular damage. Low platelet counts, increased D-dimer, and prolonged PT are linked to poor outcomes.

With the high prevalence of clotting and scattered intravascular coagulation in the country, India is expected to drive the demand for INR test meters and will likely expand at a CAGR of 8.4%, and hence functions as a major market development driver.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative Analysis of Adjacent Markets

INR Test Meter Market:

Attributes INR Test Meter Market
CAGR (2023 to 2033) 6.3%
Market Value 2023 US$ 1,336.3 million
Growth Factor Rise in the prevalence of cardiovascular diseases and blood disorders worldwide drives the growth of the INR test meter market.
Future Opportunities INR testing in smartphone sensors is anticipated to result in a cost-effective blood clot detection device with a boost in the market.
Market trends Merge in the importance of utilization of point-of-care tests, where the market for INR test meters witness high demand during the forecast period.

Blood Culture Test Market:

Attributes Blood Culture Test Market
CAGR (2023 to 2033) 5.1%
Market Value 2023 US$ 4,623 million
Growth Factor Demand for blood culture tests rises with the incidence of sepsis and other blood-related clinical conditions.
Future Opportunities Expansion of opportunities for the blood culture tests market brings a high approval rate of new products.
Market trends Growth in the aging population and advancements in medical technologies boosts the market expansion of the blood culture tests market.

Blood Glucose Test Market:

Attributes Blood Glucose Test Market
CAGR (2023 to 2033) 7.9%
Market Value 2023 US$ 3,233 million
Growth Factor Surge in the diabetic patient population, with the combination of reliability and accuracy of blood glucose monitoring devices.
Future Opportunities Boost in the number of new product launches that propels the growth of the continuous glucose monitoring devices segment.
Market trends Increase in the demand for non-invasive blood glucose will drive the market in the upward direction.

Category-wise Insights

Which Type of INR Test Meter Will Drive the Demand in the Market?

INR Test Meter Devices to Account for Significant Share Through 2033

Devices are expected to present high growth at a CAGR rate of 6.8% throughout the forecast period, accounting for around 79.7% of the revenue. INR machines and devices can be appropriately utilized in various settings, including INR self-testing and home anticoagulation therapy.

Rapid approval processes for medical devices by regulatory bodies like the FDA, and the production of advanced systems, such as digitally integrated test meters via smartphones, have provided the market with several innovative opportunities to enhance sales growth throughout the forecasted years.

Which is the Leading End User in INR Test Meter Market?

Demand for INR Test Meter in Hospitals to Surge at a Robust Pace between 2023 and 2033

Hospitals held the highest market share value of 32.4%, opines FMI. Hospital settings observe a higher adoption of the INR test meters, owing to the lower cost associated with bulk adoption of devices, greater utilization of disposable test strips, and higher patient footfall, especially in cases of trauma and emergency care.

Competitive Landscape

Some of the prominent players in the global market are-

  • F. Hoffmann-La Roche Ltd
  • Lepu Medical Technology(Beijing)Co., Ltd.
  • ACON Laboratories, Inc.
  • CoaguSense Inc.
  • Abbott
  • Eurolyser Diagnostica GmbH
  • Horiba ABX SAS
  • Avalun SAS
  • Roche Diagnostics
  • Siemens Healthineers

Some of the important developments of the key players in the market are:

  • In December 2020, F. Hoffmann-La Roche Ltd stated that it has obtained its first EU Quality Management System Certificate (IVDR) from TÜV SÜD Product Service, one of the new in Vitro Diagnostic Medical Devices Regulation's notified bodies (IVDR). The certification covers the Serum Work Area and lab coagulation product portfolio's nearly 700 catalog numbers.
  • ACON Laboratories, Inc. in October 2021, announced that its product Flowflex™ COVID-19 Antigen Home Test has been authorized for emergency use by the USA FDA.
  • In May 2023, Abbott announced a series of new programs within its multi-million-dollar initiative to increase diversity in clinical trials and improve care among under-represented populations. The new additions to Abbott's Diversity in Clinical Trials initiative build on the partnerships, scholarships, and the focus on diversified participants in the company's own clinical trials during the initiative's first year.

Report Scope

Report Attribute Details
Growth Rate CAGR of 6.3% from 2023 to 2033
Market value in 2023 US$ 1,336.2 million
Market value in 2033 US$ 2,453.3 million
Base Year for Estimation 2022
Historical Data 2017 to 2022
Forecast Period 2023 to 2033
Quantitative Units US$ million for Value and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • By Product Type
  • By End-user
  • By Region
Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East & Africa
Key Countries Profiled
  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Poland
  • Russia
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC Countries
  • South Africa
  • Israel
Key Companies Profiled
  • F. Hoffmann-La Roche Ltd
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • ACON Laboratories, Inc.
  • CoaguSense Inc.
  • Abbott
  • Eurolyser Diagnostica GmbH
  • Horiba ABX SAS
  • Avalun SAS
  • Roche Diagnostics
  • Siemens Healthineers
Customization & Pricing Available on Request

Key Market Segments Covered in INR Test Meter Industry Research

By Product:

  • Device
  • Lancet
  • Test Strips

By End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia & Pacific
  • East Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

What is the Growth Potential of the INR Test Meter Market?

The growth potential of the market is 6.3% through 2033

Which Country Holds High Lucrativeness?

The United States holds high lucrativeness.

What are the Key Opportunities for the INR Test Meter Market Manufacturers?

Application of PT/INR testing in smartphone sensors is the key opportunity.

What Leads to Growth in Germany?

Germany's INR test meter market gains from manufacturer presence.

What Makes North America a Lucrative Market for INR Test Meters?

Coagulation testing boosts demand in the United States.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and Their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyers

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Device

        5.3.2. Lancet

        5.3.3. Test Strips

    5.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Test Strips

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Test Strips, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Test Strips, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Specialty Clinics

        6.3.3. Ambulatory Surgical Centers

        6.3.4. Home care settings

    6.4. Y-o-Y Growth Trend Analysis By Test Strips, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Test Strips, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2022

    7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Product

        8.2.3. By Test Strips

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product

        8.3.3. By Test Strips

    8.4. Key Takeaways

9. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product

        9.2.3. By Test Strips

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Test Strips

    9.4. Key Takeaways

10. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. UK

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Product

        10.2.3. By Test Strips

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Test Strips

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Product

        11.2.3. By Test Strips

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Test Strips

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Product

        12.2.3. By Test Strips

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Test Strips

    12.4. Key Takeaways

13. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product

        13.2.3. By Test Strips

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Test Strips

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Product

        14.2.3. By Test Strips

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Test Strips

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Product

            15.1.2.2. By Test Strips

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Product

            15.2.2.2. By Test Strips

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Product

            15.3.2.2. By Test Strips

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Product

            15.4.2.2. By Test Strips

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Product

            15.5.2.2. By Test Strips

    15.6. UK

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Product

            15.6.2.2. By Test Strips

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Product

            15.7.2.2. By Test Strips

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Product

            15.8.2.2. By Test Strips

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Product

            15.9.2.2. By Test Strips

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Product

            15.10.2.2. By Test Strips

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Product

            15.11.2.2. By Test Strips

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Product

            15.12.2.2. By Test Strips

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Product

            15.13.2.2. By Test Strips

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Product

            15.14.2.2. By Test Strips

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Product

            15.15.2.2. By Test Strips

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Product

            15.16.2.2. By Test Strips

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Product

            15.17.2.2. By Test Strips

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Product

            15.18.2.2. By Test Strips

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Product

            15.19.2.2. By Test Strips

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Product

            15.20.2.2. By Test Strips

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Product

            15.21.2.2. By Test Strips

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Product

            15.22.2.2. By Test Strips

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Product

            15.23.2.2. By Test Strips

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product

        16.3.3. By Test Strips

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. F. Hoffmann-La Roche Ltd

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Lepu Medical Technology(Beijing)Co., Ltd.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. ACON Laboratories, Inc.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. CoaguSense Inc.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Abbott

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Eurolyser Diagnostica GmbH

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Horiba ABX SAS

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Avalun SAS

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Roche Diagnostics

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Siemens Healthineers

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Fertility and Pregnancy Rapid Test Kit Market

February 2022

REP-GB-607

October 2023

183 pages

Healthcare

Cardiac Biomarker Diagnostic Test Kits Market

December 2021

REP-GB-452

September 2023

239 pages

Technology

Test and Measurement Sensors Market

September 2017

REP-GB-5022

July 2023

342 pages

Healthcare

Cryptococcal Antigen Lateral Flow Assay Test Market

September 2024

REP-GB-1227

Upcoming

Explore Healthcare Insights

View Reports